Category: Regulatory
-
How to Determine Your Product’s Regulatory Classification
Understanding Your Product’s Place in the Regulatory Landscape When launching a medical device or health product, understanding your product classification serves as the foundation for every subsequent regulatory decision. This determination shapes your pathway to market, influences development timelines, and directly impacts your resource allocation strategy. In our year’s of experience working with medtech companies,… Read more
-
What Health & MedTech Founders Should Fix Before Starting M&A Conversations
What Founders Should Fix Before Starting M&A Conversations The M&A landscape for life science has never been more competitive. While strategic acquirers and private equity firms actively seek innovative medtech, pharma, and nutraceutical companies, they’re increasingly selective about the deals they make. In our experience working with companies through acquisition processes, the consistently same critical… Read more
-
Red Flags That Kill Medtech and Pharma Deals at the Due Diligence Stage
Red Flags That Kill Medtech and Pharma Deals at the Due Diligence Stage Regulatory compliance issues have derailed countless medtech M&A transactions and pharma deals just as they approached the finish line. In our experience working with acquirers and investment firms over 25+ years, we consistently see the same critical due diligence red flags emerge… Read more
-
How Unresolved FDA Findings Affect Deal Valuation
How Unresolved FDA Findings Affect Deal Valuation When pharmaceutical and medical device companies enter acquisition discussions, buyers scrutinize every aspect of regulatory compliance. Among the most critical factors that can derail a deal or significantly impact valuation is an unresolved FDA warning letter. In our experience working with companies across the medtech and pharma sectors,… Read more
-
Why Regulatory Readiness is the Most Overlooked Factor in M&A Valuations
When private equity firms and strategic acquirers evaluate life sciences companies, they typically focus on market size, intellectual property, and potential for financial performance. Yet one critical factor consistently gets relegated to the back burner: regulatory readiness. Our 25+ years of experience with medtech, pharma, and nutraceutical companies has caused us to witness how regulatory… Read more
-
Claims & Ingredients Compliance for Emerging Brands
Claims & Ingredients: Protect Your Brand from Exposure Expo West is a playground of innovation. You walk down the aisles and see bold promises everywhere: “Gut Healing,” “Brain Boosting,” “Zero Net Carbs,” “Sustainably Sourced.” As a founder, you know that these claims are what sell your product. They are the hook that grabs a consumer’s… Read more
-
Why Regulatory Readiness is Essential for Founders Navigating M&A Conversations
As a founder, you’re no stranger to risk-taking… But when it comes to mergers, acquisitions, or divestitures, the stakes are higher than ever. These transactions aren’t just about aligning visions or expanding market share—they’re about managing risks that could impact your brand, your team, and your bottom line. And one of the most critical risks… Read more
-
How the CTI Regulatory Readiness Check for Due Diligence Differs from a Compliance Audit
Why Regulatory Readiness is Essential for Founders Navigating M&A Conversations As a founder, you’re no stranger to risk-taking. But when it comes to mergers, acquisitions, or divestitures, the stakes are higher than ever. These transactions aren’t just about aligning visions or expanding market share—they’re about managing risks that could impact your brand, your team, and… Read more